MSCs differentiate into adipocytes, osteocytes, chondrocytes, tenocytes, marrow stromal cells, muscle, and perhaps neuronal cells and are being used in early clinical trials to enhance bone marrow grafting and to suppress graft-versus-host disease in allogeneic bone marrow transplants.

MSCs分化成脂肪细胞，骨细胞，软骨细胞，肌腱细胞，骨髓基质细胞，肌肉和神经细胞，并用于早期临床试验，以增强骨髓移植和抑制同种异体骨髓移植中的移植物抗宿主病。